• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白细胞介素在乙型肝炎病毒感染中的作用:一篇叙述性综述

The Role of Interleukins in HBV Infection: A Narrative Review.

作者信息

Dimitriadis Konstantinos, Katelani Stamatia, Pappa Maria, Fragkoulis George E, Androutsakos Theodoros

机构信息

Department of Pathophysiology, Medical School, National and Kapodistrian University of Athens, 11527 Athens, Greece.

First Department of Internal Medicine, Propaedeutic Clinic, "Laiko" Hospital, National and Kapodistrian University of Athens, 11527 Athens, Greece.

出版信息

J Pers Med. 2023 Nov 30;13(12):1675. doi: 10.3390/jpm13121675.

DOI:10.3390/jpm13121675
PMID:38138902
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10744424/
Abstract

Hepatitis B virus (HBV) infection is a worldwide medical issue with significant morbidity and mortality, as it is the main cause of chronic liver disease and hepatocellular carcinoma (HCC). Both innate and adaptive immune responses play a key role in HBV replication and suppression. Recently, the pathophysiological function of interleukins (IL) in the natural course of HBV has gained much attention as a result of the broad use of anti-interleukin agents for a variety of autoimmune diseases and the accompanying risk of HBV reactivation. We present a narrative review regarding the role of IL in HBV infection. Collectively, the pro-inflammatory ILs, namely IL-1, IL-5, IL-6, IL-12 and IL-21, seem to play a critical role in the suppression of HBV replication. In contrast, the anti-inflammatory cytokines IL-10, IL-23 and IL-35 probably act as HBV replication enhancers, while IL-17 has been correlated with HBV-related liver injury. Interestingly enough, IL-2, IL-4 and IL-12 have been tried as therapeutic options against HBV infection with contradictory results. Lastly, the role of IL-22 remains largely ill defined, although preliminary data suggest that it may play a significant role in HBV replication, proliferation and subsequent liver damage.

摘要

乙型肝炎病毒(HBV)感染是一个全球性的医学问题,具有很高的发病率和死亡率,因为它是慢性肝病和肝细胞癌(HCC)的主要病因。先天性和适应性免疫反应在HBV复制和抑制中都起着关键作用。近年来,由于抗白细胞介素药物在多种自身免疫性疾病中的广泛应用以及随之而来的HBV再激活风险,白细胞介素(IL)在HBV自然病程中的病理生理功能备受关注。我们对IL在HBV感染中的作用进行了叙述性综述。总体而言,促炎细胞因子IL-1、IL-5、IL-6、IL-12和IL-21似乎在抑制HBV复制中起关键作用。相反,抗炎细胞因子IL-10、IL-23和IL-35可能作为HBV复制增强剂,而IL-17与HBV相关肝损伤有关。有趣的是,IL-2、IL-4和IL-12已被尝试作为抗HBV感染的治疗选择,但结果相互矛盾。最后,IL-22的作用在很大程度上仍不明确,尽管初步数据表明它可能在HBV复制、增殖及随后的肝损伤中起重要作用。

相似文献

1
The Role of Interleukins in HBV Infection: A Narrative Review.白细胞介素在乙型肝炎病毒感染中的作用:一篇叙述性综述
J Pers Med. 2023 Nov 30;13(12):1675. doi: 10.3390/jpm13121675.
2
Association between Interleukin-21 and Interleukin-21 receptor gene polymorphisms with susceptibility to chronic hepatitis B virus infection and HBV spontaneous clearance in Iranian population.白细胞介素 21 与白细胞介素 21 受体基因多态性与伊朗人群慢性乙型肝炎病毒感染易感性及 HBV 自发清除的关系。
Microb Pathog. 2019 Mar;128:263-267. doi: 10.1016/j.micpath.2019.01.008. Epub 2019 Jan 10.
3
Interleukin-35 Suppresses Interleukin-9-Secreting CD4 T Cell Activity in Patients With Hepatitis B-Related Hepatocellular Carcinoma.白细胞介素-35 抑制乙型肝炎相关肝细胞癌患者分泌白细胞介素-9 的 CD4 T 细胞的活性。
Front Immunol. 2021 Jun 10;12:645835. doi: 10.3389/fimmu.2021.645835. eCollection 2021.
4
Interleukin-24 Limits Tumor-Infiltrating T Helper 17 Cell Response in Patients with Hepatitis B Virus-Related Hepatocellular Carcinoma.白细胞介素-24限制乙型肝炎病毒相关肝细胞癌患者肿瘤浸润性辅助性T细胞17反应。
Viral Immunol. 2022 Apr;35(3):212-222. doi: 10.1089/vim.2021.0174. Epub 2022 Jan 28.
5
Interleukin-34 inhibits hepatitis B virus replication in vitro and in vivo.白细胞介素-34在体外和体内均抑制乙型肝炎病毒复制。
PLoS One. 2017 Jun 14;12(6):e0179605. doi: 10.1371/journal.pone.0179605. eCollection 2017.
6
Interleukin-35 Suppresses Antiviral Immune Response in Chronic Hepatitis B Virus Infection.白细胞介素-35 在慢性乙型肝炎病毒感染中抑制抗病毒免疫反应。
Front Cell Infect Microbiol. 2017 Nov 13;7:472. doi: 10.3389/fcimb.2017.00472. eCollection 2017.
7
Elevated interleukin-35 suppresses liver inflammation by regulation of T helper 17 cells in acute hepatitis B virus infection.白细胞介素-35 升高通过调节辅助性 T 细胞 17 抑制急性乙型肝炎病毒感染的肝脏炎症。
Int Immunopharmacol. 2019 May;70:252-259. doi: 10.1016/j.intimp.2019.02.048. Epub 2019 Mar 6.
8
Association between interleukin-21 gene polymorphisms (rs12508721) and HBV-related hepatocellular carcinoma.白细胞介素-21基因多态性(rs12508721)与乙肝相关肝细胞癌之间的关联
Int J Immunogenet. 2016 Jun;43(3):151-8. doi: 10.1111/iji.12263. Epub 2016 Apr 28.
9
Rather than interleukin-27, interleukin-6 expresses positive correlation with liver severity in naïve hepatitis B infection patients.在未经治疗的乙型肝炎感染患者中,白细胞介素-6 与肝脏严重程度呈正相关,而不是白细胞介素-27。
Liver Int. 2012 Jul;32(6):928-36. doi: 10.1111/j.1478-3231.2011.02742.x. Epub 2012 Jan 9.
10
IL-17A but not IL-22 suppresses the replication of hepatitis B virus mediated by over-expression of MxA and OAS mRNA in the HepG2.2.15 cell line.IL-17A 而非 IL-22 通过上调 HepG2.2.15 细胞系中 MxA 和 OAS mRNA 抑制乙型肝炎病毒复制。
Antiviral Res. 2013 Mar;97(3):285-92. doi: 10.1016/j.antiviral.2012.12.018. Epub 2012 Dec 27.

引用本文的文献

1
Hepatitis B virus promotes liver cancer by modulating the immune response to environmental carcinogens.乙型肝炎病毒通过调节对环境致癌物的免疫反应来促进肝癌。
Nat Commun. 2025 Jun 27;16(1):5360. doi: 10.1038/s41467-025-60894-z.
2
IL-1b-Bearing NETs: Bridging Inflammation to Early Cirrhosis in Hepatitis B.携带白细胞介素-1β的中性粒细胞胞外陷阱:连接乙型肝炎炎症与早期肝硬化
Int J Mol Sci. 2025 Jun 15;26(12):5733. doi: 10.3390/ijms26125733.
3
Insights from bidirectional Mendelian randomization: Evaluating the influence of circulating inflammatory cytokines on prostatitis.

本文引用的文献

1
Interleukin-21 modulates balance between regulatory T cells and T-helper 17 cells in chronic hepatitis B virus infection.白细胞介素 21 调节慢性乙型肝炎病毒感染中调节性 T 细胞和辅助性 T 细胞 17 细胞之间的平衡。
BMC Infect Dis. 2023 Oct 24;23(1):719. doi: 10.1186/s12879-023-08723-w.
2
HBV reactivation in patients with rheumatoid arthritis treated with anti-interleukin-6: a systematic review and meta-analysis.类风湿关节炎患者接受抗白细胞介素-6 治疗后乙型肝炎病毒再激活:系统评价和荟萃分析。
Rheumatology (Oxford). 2023 Oct 23;62(SI3):SI252-SI259. doi: 10.1093/rheumatology/kead243.
3
IL-21 collaborates with anti-TIGIT to restore NK cell function in chronic HBV infection.
双向孟德尔随机化研究的见解:评估循环炎症细胞因子对前列腺炎的影响。
Medicine (Baltimore). 2025 May 9;104(19):e42438. doi: 10.1097/MD.0000000000042438.
4
Innate immune recognition in hepatitis B virus infection.乙型肝炎病毒感染中的固有免疫识别
Virulence. 2025 Dec;16(1):2492371. doi: 10.1080/21505594.2025.2492371. Epub 2025 Apr 20.
5
Hidden liver-joint axis: HBV infection causes rheumatoid arthritis via TRAFD1 with imbalance of HBV X protein and trans-ferulic acid.隐匿性肝关节轴:HBV 感染通过 TRAFD1 导致类风湿关节炎,导致 HBV X 蛋白和阿魏酸失衡。
Virulence. 2024 Dec;15(1):2422540. doi: 10.1080/21505594.2024.2422540. Epub 2024 Nov 7.
6
Tumor-associated macrophages and CD8+ T cells: dual players in the pathogenesis of HBV-related HCC.肿瘤相关巨噬细胞和 CD8+ T 细胞:HBV 相关 HCC 发病机制中的双重作用者。
Front Immunol. 2024 Oct 10;15:1472430. doi: 10.3389/fimmu.2024.1472430. eCollection 2024.
7
Host cytokine genetic polymorphisms in a selected population of persons living with hepatitis B virus infection in the central region of Ghana.加纳中部地区乙型肝炎病毒感染者中宿主细胞因子遗传多态性的研究。
BMC Gastroenterol. 2024 Oct 22;24(1):374. doi: 10.1186/s12876-024-03456-9.
8
Cytokine Response of Natural Killer Cells to Hepatitis B Virus Infection Depends on Monocyte Co-Stimulation.自然杀伤细胞对乙型肝炎病毒感染的细胞因子反应取决于单核细胞共刺激。
Viruses. 2024 May 8;16(5):741. doi: 10.3390/v16050741.
白细胞介素-21与抗TIGIT协同作用,以恢复慢性乙型肝炎病毒感染中自然杀伤细胞的功能。
J Med Virol. 2023 Oct;95(10):e29142. doi: 10.1002/jmv.29142.
4
The expression of interleukin-1β in patients with chronic hepatitis B treated with pegylated-interferon-alpha combined with tenofovir disoproxil fumarate and monotherapy.白细胞介素-1β在聚乙二醇干扰素α联合替诺福韦酯与单药治疗慢性乙型肝炎患者中的表达。
BMC Gastroenterol. 2023 May 19;23(1):163. doi: 10.1186/s12876-023-02812-5.
5
IL-22-producing CD3 + CD8- T cells increase in immune clearance stage of chronic HBV infection and correlate with the response of Peg-interferon treatment.产生白细胞介素-22的CD3 + CD8 - T细胞在慢性乙型肝炎病毒感染的免疫清除阶段增加,并与聚乙二醇干扰素治疗反应相关。
Clin Immunol. 2023 May;250:109320. doi: 10.1016/j.clim.2023.109320. Epub 2023 Apr 3.
6
JNK/c-Jun pathway activation is essential for HBx-induced IL-35 elevation to promote persistent HBV infection.JNK/c-Jun 通路的激活对于 HBx 诱导的 IL-35 升高从而促进 HBV 的持续感染是必需的。
J Clin Lab Anal. 2023 Mar;37(5):e24860. doi: 10.1002/jcla.24860. Epub 2023 Mar 14.
7
Interleukin-21 in autoimmune and inflammatory skin diseases.自身免疫性和炎性皮肤病中的白细胞介素-21
Eur J Immunol. 2023 Apr;53(4):e2250075. doi: 10.1002/eji.202250075. Epub 2023 Mar 10.
8
Serum IL-5 levels predict HBsAg seroclearance in patients treated with Nucleos(t)ide analogues combined with pegylated interferon.血清 IL-5 水平可预测核苷(酸)类似物联合聚乙二醇干扰素治疗患者的 HBsAg 血清学清除。
Front Immunol. 2023 Jan 5;13:1104329. doi: 10.3389/fimmu.2022.1104329. eCollection 2022.
9
Plasma interleukin-7 correlation with human immunodeficiency virus RNA and CD4+ T cell counts, and interleukin-5 with circulating hepatitis B virus DNA may have implications in viral control.血浆白细胞介素-7与人类免疫缺陷病毒RNA及CD4+ T细胞计数的相关性,以及白细胞介素-5与循环乙型肝炎病毒DNA的相关性,可能对病毒控制具有重要意义。
Front Med (Lausanne). 2022 Nov 3;9:1019230. doi: 10.3389/fmed.2022.1019230. eCollection 2022.
10
Serum levels of IL-12, IL-18, and IL-21 are indicators of viral load in patients chronically infected with HBV.血清中白细胞介素 12、白细胞介素 18 和白细胞介素 21 的水平是慢性乙型肝炎病毒感染者病毒载量的指标。
Braz J Med Biol Res. 2022 Nov 11;55:e12320. doi: 10.1590/1414-431X2022e12320. eCollection 2022.